RTX received $729 million in counter-drone orders from the U.S., Qatar and Jordan. AeroVironment expanded its international drone partnerships in Australia, Taiwan, Spain and Israel Ondas and Palantir to launch an AI defense firm called Regna AI. Even as bank earnings and a tech selloff dominated market headlines this week, defense stocks were in the

Image from Pixabay Investors holding Trade Desk (TTD) have seen the stock lose 74.1% of its value over the past year, compared with a 17.9% return for the S&P 500. The immediate question is how much further shares might drop. One certainty is the current level: at $13.13 on October 15, the stock sits above

Energy costs are climbing again as crude oil trades above US$100, and that pressure hits weaker balance sheets first. Canadian companies that are already investing for growth, and where executives hold meaningful stakes, can sometimes handle higher input costs and financing hurdles more confidently. This article looks at three such fast growing, high insider ownership

TomTom just reported Q3 2026 and the reaction in the stock tells you almost as much as the numbers. The share price closed at €3.8 on 16 October after a flat week and a weak 3‑month stretch, yet the latest report shows €129.0m in quarterly revenue with a 90% gross margin and positive earnings per

Nvidia (NASDAQ: NVDA) may be the world’s largest company by market cap, but that doesn’t mean that its sales and earnings can’t get bigger. However, if you look at how the stock market is valuing the company, then it’s pretty obvious that the market thinks they won’t. This gap is a major investment opportunity, because

Visa Stock Is Up 11% in October While Earnings Estimates Stood Still. Here’s What October 27 Has to Prove ©@Immagini e Video di Michelangelo via Canva, @Republica from pixabay via Canva Key Stats for Visa Inc. Stock Current Price: $399.75 Target Price (Mid): ~$680 Street Target: ~$422 Potential Total Return: ~70% Annualized IRR: ~14% /

Ladder Capital Corp Q3 2026 Earnings Call Summary – Moby Strategic Performance and Market Positioning Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we’ll show you why it’s our #1 pick. Tap here. Performance was driven by a $31 million gain from the

Salesforce Stock Is Up About 30% Since July 31. Here’s Where It Could Go by 2031 ©@Blue Planet Studio from Getty Images via Canva, @Blue Planet Studio from Getty Images via Canva Key Stats for Salesforce Stock Current Price: $246.74 Target Price (Mid): ~$445 Street Target: ~$286 Potential Total Return: ~81% Annualized IRR: ~15% /

Micron (NASDAQ: MU) has been a great stock to own in 2026, but I’m betting that it goes even higher by 2030. In fact, it could transform a $10,000 investment made today into a $42,000 position by then — and that’s on the conservative side of my estimated range. That may seem unrealistic, but the

AbbVie or Altria: The One Dividend Stock I’d Hold for the Next 10 Years ©89Stocker, towfiqu barbhuiya via Canva Key Takeaways AbbVie lowered its 2026 adjusted EPS guidance to $13.76 to $13.96 on Oct. 5, reflecting $1.25 billion of acquired IPR&D and milestone expense. Altria yields 6.2% against AbbVie’s 2.6%, while AbbVie raised its dividend

Palantir (PLTR) was breaking records earlier this week. Now its breakout has reversed, with the stock heading toward correction territory. Shares fell roughly 7% Friday, erasing about $34 billion in market value. The closing number to watch is $188.15. Below that, Palantir would finish more than 10% beneath its Oct. 9 record close, confirming a

Quick Read AAPL turned $10,000 into $127,753 over the last decade, but its $4.96T market cap limits the next 5-year base case to roughly $16,271. iPhone 17 revenue surged 22% to $54B and Services hit $30.7B, powering a record $109B June quarter for Apple. Valuation at 39x earnings, shrinking gross margins, and iPhone 18 Pro

CoreWeave (CRWV) sprang a bear trap Thursday. Now another sell-off is testing whether the bulls can hold their ground. The AI cloud provider’s shares are falling Friday after staging a dramatic reversal the previous session. Shares briefly broke below their summer floor near $60 on Thursday, sank to $59.51, then climbed to $69.76 — a

What happened: Moderna (MRNA) stock tanked 9% on Friday. What’s behind the move: The biotech giant sank as investors took profits and Wall Street grew cautious on the stock’s blistering rally of more than 600% year to date. Goldman Sachs (GS) raised its target on the stock to $137 from $120 on Thursday while maintaining a Neutral